2016/04/14 - 2015 annual report : acceleration of clinical trials, secured financing and internationalisation in progress

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces that its 2015 annual report is available and issues a report on the highlights from 2015 and the start of 2016.

Download Press Release